drugset
drugset / Trial / NCT06561594

To Evaluate Recombinant Human Follicle Stimulating Hormone-CTP Fusion Protein Injection or Placebo Combined With Chorionic Gonadotropin for Injection

NCT06561594 ↗

Phase 3 Not yet recruiting 60 enrolled Changchun GeneScience Pharmaceutical Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study was conducted to evaluate recombinant human follicle stimulating hormone-CTP fusion protein injection or placebo combined with chorionic gonadotropin for injection

Timeline

Start
2024-09-20
Primary completion
2024-11-23
Completion
2026-12-23

Drugs

EvaluationDrugModalityDoseRoute
Subject GenSci094 Protein / enzyme biologic 100 ug —
Subject GenSci094 Protein / enzyme biologic 150 ug —

Indications

hypogonadotropic hypogonadism